Treatment.com AI Inc. (TREIF)
| Market Cap | 18.80M |
| Revenue (ttm) | 28.19K |
| Net Income (ttm) | -1.49M |
| Shares Out | n/a |
| EPS (ttm) | -0.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,378 |
| Open | 0.350 |
| Previous Close | 0.399 |
| Day's Range | 0.350 - 0.390 |
| 52-Week Range | 0.047 - 0.912 |
| Beta | -0.45 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Dec 5, 2024 |
About Treatment.com AI
Treatment.Com International Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Treatment.Com International Inc. was incorporated in 2018 and... [Read more]
News
Treatment.com AI Announces Release of New Medical Education Suite (MES) and Update on the AI Assessment Symposium 1st November, 2024
● Treatment.com AI announces expanded and updated MES new releases ● Lead commercial participant at Global/North American Symposium on AI Assessment in Medical Education ● Further enhancements and sol...
REPEAT: TREATMENT.COM AI INC. CLOSES OVER-SUBSCRIBED NON- BROKERED PRIVATE PLACEMENT OF $1,954,074
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States. Not for d...
TREATMENT.COM AI INC. CLOSES OVER-SUBSCRIBED NON- BROKERED PRIVATE PLACEMENT OF $1,954,074
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States. Not for d...
Repeat: Treatment.com AI to Present at the 2024 Cantech Letter Conference in Toronto, ON
Treatment.com AI CEO, Dr. Essam Hamza, is to present live at 11:00 AM ET on Wednesday, October 9, 2024. VANCOUVER, British Columbia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE,...
Treatment.com AI to Present at The 2024 Cantech Letter Conference in Toronto, ON
Treatment.com AI CEO, Dr. Essam Hamza, is to present live at 11:00 AM ET on Wednesday, October 9, 2024 Vancouver, British Columbia--(Newsfile Corp. - October 1, 2024) - Treatment.com AI Inc. (CSE: TRU...
Repeat: Treatment.com AI Medical Education Corporate Update and Updates on Additional Marketing Engagements
VANCOUVER, British Columbia, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to provide marketing updates and a general corpor...
Treatment.com AI Medical Education Corporate Update and Updates on Additional Marketing Engagements
VANCOUVER, British Columbia, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to provide marketing updates and a general corpor...
Repeat: Treatment.com AI and SPRYT Join Forces to Improve Patient Access to Healthcare Services
VANCOUVER, British Columbia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreeme...
Treatment.com AI and SPRYT Join Forces to Improve Patient Access to Healthcare Services
VANCOUVER, British Columbia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreeme...
Repeat: Treatment.com AI and University of Edinburgh Join Forces to Transform Long-Term Care Services across the UK
VANCOUVER, British Columbia, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreeme...
Treatment.com AI and University of Edinburgh Join Forces to Transform Long-Term Care Services across the UK
VANCOUVER, British Columbia, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreeme...
Repeat: Treatment.com AI - Revolutionizing Healthcare: Harnessing the Power of AI for Transformative Patient Care
VANCOUVER, British Columbia, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Company” or “Treatment”), a healthcare tech company transforming patient ...
Treatment.com AI - Revolutionizing Healthcare: Harnessing the Power of AI for Transformative Patient Care
VANCOUVER, British Columbia, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Company” or “Treatment”), a healthcare tech company transforming patient ...
Repeat: Treatment.com AI announces AI Pharmacy Assistant
VANCOUVER, British Columbia, July 31, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Company” or “Treatment”), a healthcare tech company transforming patient ...
Treatment.com AI announces AI Pharmacy Assistant
VANCOUVER, British Columbia, July 31, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Company” or “Treatment”), a healthcare tech company transforming patient ...
Repeat: Treatment.com AI Provides an Update on the Status of Exercised Warrants
● ~800,000 warrants exercised since free trading was announced raising close to half a million dollars. ● Remaining warrants could bring over $2 million in additional funds.
Treatment.com AI Provides an Update on the Status of Exercised Warrants
● ~800,000 warrants exercised since free trading was announced raising close to half a million dollars. ● Remaining warrants could bring over $2 million in additional funds.
Repeat: Treatment.com AI Provides Latest Corporate Update
● Positive Financial Update ● New Partnerships Announced - aiXplain/Novus Health ● GLM - AI Accuracy and Effectiveness in Healthcare ● Bolstering the Executive, Scientific and Development Team - Dr. J...
Treatment.com AI Provides Latest Corporate Update
● Positive Financial Update ● New Partnerships Announced - aiXplain/Novus Health ● GLM - AI Accuracy and Effectiveness in Healthcare ● Bolstering the Executive, Scientific and Development Team - Dr. J...
Treatment.com AI Announces Appointment of Richard Atkins as Chief Operating Officer and Executive Team member
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”), a healthcare tech company transforming patie...
Treatment.com AI Announces Contract Renewal with Leading US Medical School
VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is excited to announce one of the leading US ...
Treatment.com AI Announces New Additions to its Medical Education Suite (MES)
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) is excited to announce two new solution...
Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM)
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreeme...
Treatment.com AI Funded by the National Institute of Health to Develop a Culturally Sensitive AI Approach to Health Equity
VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that the Company has...
Treatment AI Passes Medical School Clinical Exam with 92% Success Rate
VANCOUVER, British Columbia, March 20, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that it's AI medical...